Expression of Concern: miR-139 is up-regulated in osteoarthritis and inhibits chondrocyte proliferation and migration possibly via suppressing EIF4G2 and IGF1R (Biochemical and Biophysical Research Communications (2016) 474(2) (296–302), (S0006291X16304119), (10.1016/j.bbrc.2016.03.164));MIR-139 is up-regulated in osteoarthritis and inhibits chondrocyte proliferation and migration possibly via suppressing EIF4G2 and IGF1R

Biochemical and Biophysical Research Communications

Volumn 474, Issue 2, 2016, Pages 296-302

  Hu, Weihua ^a   Zhang, Weikai ^a   Li, Feng ^a   Guo, Fengjing ^a   Chen, Anmin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Cell proliferation and migration; EIF4G2; IGF1R; MIR 139; Osteoarthritis

Indexed keywords

EUKARYOTIC TRANSLATION INITIATION FACTOR 4 GAMMA 2; INITIATION FACTOR; MICRORNA; MICRORNA 139; SMALL INTERFERING RNA; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG; EIF4G2 PROTEIN, HUMAN; IGF1R PROTEIN, HUMAN; INITIATION FACTOR 4G; MIRN139 MICRORNA, HUMAN; SOMATOMEDIN RECEPTOR;

ADULT; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; MALE; MTT ASSAY; OSTEOARTHRITIS; PRIORITY JOURNAL; REGULATORY MECHANISM; UPREGULATION; CELL MOTION; CHONDROCYTE; KNEE OSTEOARTHRITIS; METABOLISM; MIDDLE AGED; PATHOLOGY;

CELL MOVEMENT; CELL PROLIFERATION; CHONDROCYTES; EUKARYOTIC INITIATION FACTOR-4G; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; OSTEOARTHRITIS, KNEE; RECEPTORS, SOMATOMEDIN; UP-REGULATION;

EID: 84964663173     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2021.11.053     Document Type: Erratum

References (32)

1. T. Vos, A.D. Flaxman, M. Naghavi, R. Lozano, C. Michaud, and et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the global burden of disease study 2010 Lancet 380 2012 2163 2196
2. D. Yu, G. Peat, J. Bedson, and K.P. Jordan Annual consultation incidence of osteoarthritis estimated from population-based health care data in England Rheumatol. Oxf. 54 2015 2051 2060
3. J.S. Mort, and C.J. Billington Articular cartilage and changes in arthritis: matrix degradation Arthritis Res. 3 2001 337 341
4. M. Fuerst, J. Bertrand, L. Lammers, R. Dreier, F. Echtermeyer, and et al. Calcification of articular cartilage in human osteoarthritis Arthritis Rheum. 60 2009 2694 2703
5. J.R. Kanwar, R.K. Kanwar, H. Burrow, and S. Baratchi Recent advances on the roles of NO in cancer and chronic inflammatory disorders Curr. Med. Chem. 16 2009 2373 2394
6. R.M. Samarasinghe, R.K. Kanwar, and J.R. Kanwar The effect of oral administration of iron saturated-bovine lactoferrin encapsulated chitosan-nanocarriers on osteoarthritis Biomaterials 35 2014 7522 7534
7. V. Contreras, M.A. Richardson, E. Hao, and B.D. Keiper Depletion of the cap-associated isoform of translation factor eIF4G induces germline apoptosis in C. elegans Cell Death Differ. 15 2008 1232 1242
8. M.J. Coldwell, J.L. Cowan, M. Vlasak, A. Mead, M. Willett, and et al. Phosphorylation of eIF4GII and 4E-BP1 in response to nocodazole treatment: a reappraisal of translation initiation during mitosis Cell Cycle 12 2013 3615 3628
9. L. Tu, Z. Liu, X. He, Y. He, H. Yang, and et al. Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma Mol. Cancer 9 2010 1 11
10. E.K. Maloney, J.L. McLaughlin, N.E. Dagdigian, L.M. Garrett, K.M. Connors, and et al. An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation Cancer Res. 63 2003 5073 5083
11. T.J. Liu, T. LaFortune, T. Honda, O. Ohmori, S. Hatakeyama, and et al. Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo Mol. Cancer Ther. 6 2007 1357 1367
12. M.J. Barter, S. Woods, and D.A. Young microRNA in chondrogenesis, cartilage and osteoarthritis Curr. Rheumatol. Rev. 8 2012 88 97
13. L.T. Le, T.E. Swingler, N. Crowe, T.L. Vincent, M.J. Barter, and et al. The microRNA-29 family in cartilage homeostasis and osteoarthritis J. Mol. Med. (Berl). 2015 1 14
14. Z.C. Li, N. Han, X. Li, G. Li, Y.Z. Liu, and et al. Decreased expression of microRNA-130a correlates with TNF-α in the development of osteoarthritis Int. J. Clin. Exp. Pathol. 8 2015 2555 2564
15. X. Li, G. Gibson, J.S. Kim, J. Kroin, S. Xu, and et al. MicroRNA-146a is linked to pain-related pathophysiology of osteoarthritis Gene 480 2011 34 41
16. M.S. Makki, and T.M. Haqqi miR-139 modulates MCPIP1/IL-6 expression and induces apoptosis in human OA chondrocytes Exp. Mol. Med. 47 2015 e189
17. M.S. Makki, and T.M. Haqqi miR-139 is overexpressed in human OA cartilage and regulates MCPIP1/IL6 expression in human OA chondrocytes Osteoarthr. Cartil. 23 2015 A156 A157
18. V. Agarwal, G.W. Bell, J.W. Nam, and D.P. Bartel Predicting effective microRNA target sites in mammalian mRNAs eLife 4 2015 e05005
19. S. Emmrich, F. Engeland, M. El-Khatib, K. Henke, A. Obulkasim, and et al. miR-139-5p controls translation in myeloid leukemia through EIF4G2 Oncogene 35 2015 1822 1831
20. K. Shen, R. Mao, L. Ma, Y. Li, Y. Qiu, and et al. A post-transcriptional regulation of tumor suppressor MiR-139-5p and a network of MiR-139-5p mediated mRNAs interactions in colorectal cancer Febs J. 281 2014
21. R. Mao, F. Zou, L. Yang, S. Lin, Y. Li, and et al. The loss of MiR-139-5p promotes colitis-associated tumorigenesis by mediating PI3K/AKT/Wnt signaling Cell Biol. 69 2015 153 161
22. W.E. Marissen, A. Gradi, N. Sonenberg, and R.E. Lloyd Cleavage of eukaryotic translation initiation factor 4GII correlates with translation inhibition during apoptosis Cell Death Differ. 7 2000 1234 1243
23. K. Mazan-Mamczarz, X.F. Zhao, B. Dai, J.J. Steinhardt, R.J. Peroutka, and et al. Down-regulation of eIF4GII by miR-520c-3p represses diffuse large B cell lymphoma development PloS Genet. 10 2014 e1004105
24. T.A. Sutton, T. Hato, E. Mai, M. Yoshimoto, S. Kuehl, and et al. p53 is renoprotective after ischemic kidney injury by reducing inflammation J. Am. Soc. Nephrol. 24 2013 113 124
25. C.Y. Jia, H.H. Li, X.C. Zhu, Y.W. Dong, D. Fu, and et al. MiR-223 suppresses cell proliferation by targeting IGF-1R PLoS One 6 2011 e27008
26. W. Xu, M. Hang, C.Y. Yuan, F.L. Wu, S.B. Chen, and et al. MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer Int. J. Clin. Exp. Pathol. 8 2015 3864 3870
27. W. Gu, X. Li, and J. Wang miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway Oncol. Rep. 31 2014 397 404
28. C.C. Wong, C.M. Wong, E.K. Tung, S.L. Au, J.M. Lee, and et al. The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2 Gastroenterology 140 2011 322 331
29. H.N. Luo, Z.H. Wang, Y. Sheng, Q. Zhang, J. Yan, and et al. MiR-139 targets CXCR4 and inhibits the proliferation and metastasis of laryngeal squamous carcinoma cells Med. Oncol. 31 2014 789
30. L. Rask, E. Balslev, R. Søkilde, E. Høgdall, H. Flyger, and et al. Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status Cell Oncol. (Dordr) 37 2014 215 227
31. K. Shen, Q. Liang, K. Xu, D. Cui, L. Jiang, and et al. MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor Biochem. Pharmacol. 84 2012 320 330
32. S. Miyaki, and H. Asahara Macro view of microRNA function in osteoarthritis Nat. Rev. Rheumatol. 8 2012 543 552